Archives
Cholesterol Hinders Lipid Nanoparticle Trafficking
2026-08-13
This study introduces a sensitive imaging platform to track nucleic acid-containing lipid nanoparticles through endocytotic and endolysosomal compartments. Its central finding is that increasing cholesterol can promote aggregation of LNP-containing early endosomes near the cell periphery, hindering trafficking toward compartments associated with cargo release.
Aurora A, SAM Metabolism, and Trained Immunity
2026-08-13
Li et al. identify Aurora kinase A as a metabolic and epigenetic regulator of β-glucan-trained immunity, linking kinase activity to the mTOR–FOXO3–GNMT axis and endogenous S-adenosylmethionine availability. The study provides a mechanistic framework for interpreting how Aurora A inhibition can alter inflammatory chromatin states and immune-mediated tumor responses.
(+)-Bicuculline: Protocol and QC Guide
2026-08-12
(+)-Bicuculline (SKU N1592) provides a controlled pharmacological perturbation of GABAA-mediated inhibition for neuroscience research workflows, including synaptic signaling and selected memory-model studies. It is a research-use compound only and should not be used for diagnostic, clinical, or therapeutic applications.
Vitamin C (CAS 50-81-7): Assay Reliability
2026-08-12
This scenario-based guide explains how Vitamin C (CAS 50-81-7), SKU B2064, can support more interpretable cell viability, proliferation, senescence, and cytotoxicity experiments. It combines product specifications with peer-reviewed evidence and practical controls for dosing, preparation, and data interpretation.
Perphenazine: From D2 Signaling to Host Defense
2026-08-11
Perphenazine is a dopamine D2 receptor antagonist with a distinctive research profile spanning receptor pharmacology, mitochondrial injury, opioid tolerance suppression, and macrophage defense. This article presents an evidence-based framework for separating target engagement from cell stress and host-directed antibacterial activity.
DPPH: From Radical Signal to Study Decisions
2026-08-11
DPPH and 2,2-Diphenyl-1-Picrylhydrazyl Radical chemistry provide a rapid foundation for in vitro antioxidant screening. This guide explains how to interpret DPPH results alongside orthogonal assays, analytical profiling, and natural-product decision workflows.
Cholesterol Hinders LNP Intracellular Trafficking
2026-08-10
The 2025 International Journal of Pharmaceutics study introduced a sensitive imaging platform to follow nucleic acid-loaded lipid nanoparticles through intracellular compartments. Its results indicate that increasing cholesterol can promote aggregation of LNP-containing early endosomes, restrict endolysosomal progression, and reduce access to compartments associated with cargo release.
Breast Cancer Dependence on MCL-1: Study Insights
2026-08-09
This 2021 study shows that established breast tumours depend on MCL-1 primarily because of its canonical anti-apoptotic activity, rather than an exclusively non-apoptotic function. Genetic deletion and pharmacological inhibition both required BAX/BAK to suppress tumour growth, linking MCL-1 targeting directly to mitochondrial apoptosis and offering a framework for interpreting MCL-1 inhibitor studies.
Aprotinin at the Translational Frontier
2026-08-08
A mechanistic and strategic guide to Aprotinin, or bovine pancreatic trypsin inhibitor, connecting fibrinolysis inhibition, cardiovascular surgery blood management, inflammation, and red blood cell membrane biomechanics.
Cell Cycle Assay Kit: Workflow & Troubleshooting
2026-08-07
Turn DNA-content histograms into actionable evidence of cell-cycle arrest, proliferation changes, and apoptosis. This workflow shows how the Cell Cycle Assay Kit (K2263) can strengthen oncology experiments, including studies of GANT61-treated ALK-positive anaplastic large cell lymphoma.
Sodium Nitroprusside: Applied Workflows in Vascular Hyperten
2026-08-07
Sodium Nitroprusside empowers researchers to dissect sex-specific vascular responses and optimize hypertension models via precise nitric oxide donation. This article delivers step-by-step protocols, advanced assay design, and troubleshooting strategies informed by landmark studies. Discover how APExBIO’s reagent unlocks nuanced control in vascular smooth muscle and platelet function research.
SLC2A5-Driven Fructose Metabolism in Primary CNS Lymphoma
2026-08-06
This study uses single-cell multi-omics to reveal how SLC2A5-mediated fructose metabolism becomes a metabolic vulnerability in primary CNS lymphoma (PCNSL) under hypoxic, glucose-deprived conditions. The findings highlight therapeutic opportunities targeting fructose uptake in both tumor cells and supportive macrophages, with implications for future metabolic intervention strategies.
MK-571 (L-660,711): Applied Workflows in Inflammation Resear
2026-08-06
MK-571 (L-660,711) stands out as both a precise leukotriene D4 receptor antagonist and a robust tool for dissecting multidrug resistance in immune assays. Recent mechanistic studies open new avenues for optimizing immune cell protection protocols and deepening our understanding of inflammation and chemotherapy cross-talk.
Standardized Whole-Blood Stimulation for Immunometabolic Ana
2026-08-05
This study introduces a rigorously standardized protocol for assessing immune responses in human whole blood under metabolic modulation. By integrating selective metabolic pathway inhibitors, the research enables reproducible and mechanistic exploration of immunometabolic crosstalk, with implications for both basic research and translational immunology.
SOAT1 Inhibition Restores Lipophagy in PHMG-Induced Lung Fib
2026-08-05
This study identifies SOAT1 as a critical mediator in PHMG-induced pulmonary fibrosis, showing that its inhibition restores lipophagy and reduces pro-fibrotic foam cell formation. The findings suggest new therapeutic strategies for toxicant-induced and metabolic lung diseases.
3689 records 11/246 page Previous Next First page 上5页 1112131415 下5页 Last page